Lvw Advisors, LLC Merrimack Pharmaceuticals Inc Transaction History

Lvw Advisors, LLC

  • $771 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021
SELL
$3.69 - $8.31 $73,800 - $166,200
-20,000 Closed
0 $0
Q3 2020

Oct 29, 2020
BUY
$3.1 - $4.3 $62,000 - $86,000
20,000 New
20,000 $80,000
Q2 2020

Aug 11, 2020
SELL
$2.21 - $3.88 $153,137 - $268,856
-69,293 Closed
0 $0
Q1 2020

Apr 23, 2020
SELL
$1.63 - $3.58 $2,467 - $5,420
-1,514 Reduced 2.14%
69,293 $149,000
Q4 2019

Feb 10, 2020
BUY
$3.15 - $4.67 $7,245 - $10,741
2,300 Added 3.36%
70,807 $223,000
Q3 2019

Oct 22, 2019
BUY
$4.16 - $6.05 $284,989 - $414,467
68,507 New
68,507 $308,000

Others Institutions Holding MACK

# of Institutions
1
Shares Held
77
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Lvw Advisors, LLC Portfolio

Follow Lvw Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email